Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Elevated Complement C3 and C4 Levels are Associated with Postnatal Pregnancy-Related Venous Thrombosis.

Dahm AEA, Jacobsen EM, Wik HS, Jacobsen AF, Mollnes TE, Kanse SM, Sandset PM.

Thromb Haemost. 2019 Jun 29. doi: 10.1055/s-0039-1692426. [Epub ahead of print]

PMID:
31254974
2.

Urokinase-type plasminogen activator (uPA) is not essential for epithelial sodium channel (ENaC)-mediated sodium retention in experimental nephrotic syndrome.

Bohnert BN, Daiminger S, Wörn M, Sure F, Staudner T, Ilyaskin AV, Batbouta F, Janessa A, Schneider JC, Essigke D, Kanse S, Haerteis S, Korbmacher C, Artunc F.

Acta Physiol (Oxf). 2019 Apr 21:e13286. doi: 10.1111/apha.13286. [Epub ahead of print]

PMID:
31006168
3.

Post-transcriptional, post-translational and pharmacological regulation of tissue factor pathway inhibitor.

Subramaniam S, Kanse SM, Kothari H, Reinhardt C, Fletcher C.

Blood Coagul Fibrinolysis. 2018 Dec;29(8):668-682. doi: 10.1097/MBC.0000000000000775. Review.

PMID:
30439766
4.

Genetics of the thrombomodulin-endothelial cell protein C receptor system and the risk of early-onset ischemic stroke.

Cole JW, Xu H, Ryan K, Jaworek T, Dueker N, McArdle P, Gaynor B, Cheng YC, O'Connell J, Bevan S, Malik R, Ahmed NU, Amouyel P, Anjum S, Bis JC, Crosslin D, Danesh J, Engelter ST, Fornage M, Frossard P, Gieger C, Giese AK, Grond-Ginsbach C, Ho WK, Holliday E, Hopewell J, Hussain M, Iqbal W, Jabeen S, Jannes J, Kamal A, Kamatani Y, Kanse S, Kloss M, Lathrop M, Leys D, Lindgren A, Longstreth WT Jr, Mahmood K, Meisinger C, Metso TM, Mosley T Jr, Müller-Nurasyid M, Norrving B, Parati E, Peters A, Pezzini A, Quereshi I, Rasheed A, Rauf A, Salam T, Shen J, Słowik A, Stanne T, Strauch K, Tatlisumak T, Thijs VN, Tiedt S, Traylor M, Waldenberger M, Walters M, Zhao W, Boncoraglio G, Debette S, Jern C, Levi C, Markus H, Meschia J, Rolfs A, Rothwell P, Saleheen D, Seshadri S, Sharma P, Sudlow C, Worrall B; METASTROKE Consortium of the ISGC; WTCCC-2 Consortium, Stine OC, Kittner SJ, Mitchell BD.

PLoS One. 2018 Nov 1;13(11):e0206554. doi: 10.1371/journal.pone.0206554. eCollection 2018.

5.

Altered structure and function of fibrinogen after cleavage by Factor VII Activating Protease (FSAP).

Etscheid M, Subramaniam S, Lochnit G, Zabczyk M, Undas A, Lang IM, Hanschmann KM, Kanse SM.

Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3397-3406. doi: 10.1016/j.bbadis.2018.07.030. Epub 2018 Aug 1.

PMID:
30076961
6.

Genome-wide analysis of genetic determinants of circulating factor VII-activating protease (FSAP) activity.

Olsson M, Stanne TM, Pedersen A, Lorentzen E, Kara E, Martinez-Palacian A, Rønnow Sand NP, Jacobsen AF, Sandset PM, Sidelmann JJ, Engström G, Melander O, Kanse SM, Jern C.

J Thromb Haemost. 2018 Oct;16(10):2024-2034. doi: 10.1111/jth.14258. Epub 2018 Aug 24.

7.

The pseudophosphatase STYX targets the F-box of FBXW7 and inhibits SCFFBXW7 function.

Reiterer V, Figueras-Puig C, Le Guerroue F, Confalonieri S, Vecchi M, Jalapothu D, Kanse SM, Deshaies RJ, Di Fiore PP, Behrends C, Farhan H.

EMBO J. 2018 Mar 15;37(6). pii: e99170. doi: 10.15252/embj.201899170. No abstract available.

8.

Plasminogen Activator Inhibitor-1 Promotes Neutrophil Infiltration and Tissue Injury on Ischemia-Reperfusion.

Praetner M, Zuchtriegel G, Holzer M, Uhl B, Schaubächer J, Mittmann L, Fabritius M, Fürst R, Zahler S, Funken D, Lerchenberger M, Khandoga A, Kanse S, Lauber K, Krombach F, Reichel CA.

Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):829-842. doi: 10.1161/ATVBAHA.117.309760. Epub 2018 Jan 25.

PMID:
29371242
9.

Interaction of factor VII activating protease (FSAP) with neutrophil extracellular traps (NETs).

Grasso S, Neumann A, Lang IM, Etscheid M, von Köckritz-Blickwede M, Kanse SM.

Thromb Res. 2018 Jan;161:36-42. doi: 10.1016/j.thromres.2017.11.012. Epub 2017 Nov 21.

PMID:
29178989
10.

A Positively Charged Surface Triggers Coagulation Activation Through Factor VII Activating Protease (FSAP).

Sperling C, Maitz MF, Grasso S, Werner C, Kanse SM.

ACS Appl Mater Interfaces. 2017 Nov 22;9(46):40107-40116. doi: 10.1021/acsami.7b14281. Epub 2017 Nov 9.

PMID:
29091393
11.

Factor VII activating protease (FSAP) regulates the expression of inflammatory genes in vascular smooth muscle and endothelial cells.

Byskov K, Boettger T, Ruehle PF, Nielsen NV, Etscheid M, Kanse SM.

Atherosclerosis. 2017 Oct;265:133-139. doi: 10.1016/j.atherosclerosis.2017.08.029. Epub 2017 Aug 25.

PMID:
28881271
12.

A novel hypoxia response element regulates oxygen-related repression of tissue factor pathway inhibitor in the breast cancer cell line MCF-7.

Cui XY, Skretting G, Tinholt M, Stavik B, Dahm AEA, Sahlberg KK, Kanse S, Iversen N, Sandset PM.

Thromb Res. 2017 Sep;157:111-116. doi: 10.1016/j.thromres.2017.07.013. Epub 2017 Jul 14.

PMID:
28734156
13.

Analysis of the substrate specificity of Factor VII activating protease (FSAP) and design of specific and sensitive peptide substrates.

Kara E, Manna D, Løset GÅ, Schneider EL, Craik CS, Kanse S.

Thromb Haemost. 2017 Aug 30;117(9):1750-1760. doi: 10.1160/TH17-02-0081. Epub 2017 Jul 20.

PMID:
28726978
14.

Tissue factor pathway inhibitor attenuates ER stress-induced inflammation in human M2-polarized macrophages.

Espada S, Stavik B, Holm S, Sagen EL, Bjerkeli V, Skjelland M, Dahl TB, Espevik T, Kanse S, Sandset PM, Skretting G, Halvorsen B.

Biochem Biophys Res Commun. 2017 Sep 16;491(2):442-448. doi: 10.1016/j.bbrc.2017.07.070. Epub 2017 Jul 13.

PMID:
28712870
15.

Factor VII activating protease (FSAP) influences vascular remodeling in the mouse hind limb ischemia model.

Herold J, Nowak S, Kostin S, Daniel JM, Francke A, Subramaniam S, Braun-Dullaeus RC, Kanse SM.

Am J Transl Res. 2017 Jun 15;9(6):3084-3095. eCollection 2017.

16.

Deposition and spatial variation of thoron decay products in a thoron experimental house using the Direct Thoron Progeny Sensors.

Mishra R, Joshi M, Meisenberg O, Gierl S, Prajith R, Kanse SD, Rout R, Sapra BK, Mayya YS, Tschiersch J.

J Radiol Prot. 2017 Jun 26;37(2):379-389. doi: 10.1088/1361-6498/aa6408. Epub 2017 Apr 18.

PMID:
28418936
17.

The pseudophosphatase STYX targets the F-box of FBXW7 and inhibits SCFFBXW7 function.

Reiterer V, Figueras-Puig C, Le Guerroue F, Confalonieri S, Vecchi M, Jalapothu D, Kanse SM, Deshaies RJ, Di Fiore PP, Behrends C, Farhan H.

EMBO J. 2017 Feb 1;36(3):260-273. doi: 10.15252/embj.201694795. Epub 2016 Dec 22. Erratum in: EMBO J. 2018 Mar 15;37(6):.

18.

Radon and thoron inhalation doses in dwellings with earthen architecture: Comparison of measurement methods.

Meisenberg O, Mishra R, Joshi M, Gierl S, Rout R, Guo L, Agarwal T, Kanse S, Irlinger J, Sapra BK, Tschiersch J.

Sci Total Environ. 2017 Feb 1;579:1855-1862. doi: 10.1016/j.scitotenv.2016.11.170. Epub 2016 Dec 8.

PMID:
27939079
19.

Factor VII-activating protease deficiency promotes neointima formation by enhancing leukocyte accumulation.

Daniel JM, Reichel CA, Schmidt-Woell T, Dutzmann J, Zuchtriegel G, Krombach F, Herold J, Bauersachs J, Sedding DG, Kanse SM.

J Thromb Haemost. 2016 Oct;14(10):2058-2067. doi: 10.1111/jth.13417. Epub 2016 Sep 7.

20.

Perivascular Mast Cells Govern Shear Stress-Induced Arteriogenesis by Orchestrating Leukocyte Function.

Chillo O, Kleinert EC, Lautz T, Lasch M, Pagel JI, Heun Y, Troidl K, Fischer S, Caballero-Martinez A, Mauer A, Kurz ARM, Assmann G, Rehberg M, Kanse SM, Nieswandt B, Walzog B, Reichel CA, Mannell H, Preissner KT, Deindl E.

Cell Rep. 2016 Aug 23;16(8):2197-2207. doi: 10.1016/j.celrep.2016.07.040. Epub 2016 Aug 11.

21.

Transforming Growth Factor-β (TGF-β) Inhibits the Expression of Factor VII-activating Protease (FSAP) in Hepatocytes.

Leiting S, Seidl S, Martinez-Palacian A, Muhl L, Kanse SM.

J Biol Chem. 2016 Sep 30;291(40):21020-21028. Epub 2016 Jul 26.

22.

Factor seven activating protease (FSAP) predicts response to intravenous thrombolysis in acute ischemic stroke.

Bustamante A, Díaz-Fernández B, Giralt D, Boned S, Pagola J, Molina CA, García-Berrocoso T, Kanse SM, Montaner J.

Int J Stroke. 2016 Aug;11(6):646-55. doi: 10.1177/1747493016641949. Epub 2016 Apr 12.

PMID:
27073188
23.

Genome-Wide Association Analysis of Young-Onset Stroke Identifies a Locus on Chromosome 10q25 Near HABP2.

Cheng YC, Stanne TM, Giese AK, Ho WK, Traylor M, Amouyel P, Holliday EG, Malik R, Xu H, Kittner SJ, Cole JW, O'Connell JR, Danesh J, Rasheed A, Zhao W, Engelter S, Grond-Ginsbach C, Kamatani Y, Lathrop M, Leys D, Thijs V, Metso TM, Tatlisumak T, Pezzini A, Parati EA, Norrving B, Bevan S, Rothwell PM, Sudlow C, Slowik A, Lindgren A, Walters MR; WTCCC-2 Consortium, Jannes J, Shen J, Crosslin D, Doheny K, Laurie CC, Kanse SM, Bis JC, Fornage M, Mosley TH, Hopewell JC, Strauch K, Müller-Nurasyid M, Gieger C, Waldenberger M, Peters A, Meisinger C, Ikram MA, Longstreth WT Jr, Meschia JF, Seshadri S, Sharma P, Worrall B, Jern C, Levi C, Dichgans M, Boncoraglio GB, Markus HS, Debette S, Rolfs A, Saleheen D, Mitchell BD.

Stroke. 2016 Feb;47(2):307-16. doi: 10.1161/STROKEAHA.115.011328. Epub 2016 Jan 5.

24.

Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer.

Cui XY, Tinholt M, Stavik B, Dahm AE, Kanse S, Jin Y, Seidl S, Sahlberg KK, Iversen N, Skretting G, Sandset PM.

J Thromb Haemost. 2016 Feb;14(2):387-96. doi: 10.1111/jth.13206. Epub 2016 Jan 30.

25.

Effect of 220Rn gas concentration distribution on its transmission from a delay chamber: evolving a CFD-based uniformity index.

Agarwal TK, Joshi M, Sahoo BK, Kanse SD, Sapra BK.

Radiat Prot Dosimetry. 2016 Mar;168(4):546-52. doi: 10.1093/rpd/ncv361. Epub 2015 Jul 7.

PMID:
26152566
26.

Estimation of EEC, unattached fraction and equilibrium factor for the assessment of radiological dose using pin-hole cup dosimeters and deposition based progeny sensors.

Bangotra P, Mehra R, Kaur K, Kanse S, Mishra R, Sahoo BK.

J Environ Radioact. 2015 Oct;148:67-73. doi: 10.1016/j.jenvrad.2015.06.010. Epub 2015 Jun 25.

PMID:
26117280
27.

Estimation of attached and unattached progeny of 222Rn and 220Rn concentration using deposition based progeny sensors.

Mehra R, Bangotra P, Kaur K, Kanse S, Mishra R.

Radiat Prot Dosimetry. 2015 Nov;167(1-3):92-6. doi: 10.1093/rpd/ncv223. Epub 2015 May 8.

PMID:
25956782
28.

Ferric chloride-induced arterial thrombosis in mice.

Subramaniam S, Kanse SM.

Curr Protoc Mouse Biol. 2014 Dec 11;4(4):151-64. doi: 10.1002/9780470942390.mo140140.

PMID:
25723183
29.

Components of the plasminogen activation system promote engraftment of porous polyethylene biomaterial via common and distinct effects.

Reichel CA, Hessenauer ME, Pflieger K, Rehberg M, Kanse SM, Zahler S, Krombach F, Berghaus A, Strieth S.

PLoS One. 2015 Feb 6;10(2):e0116883. doi: 10.1371/journal.pone.0116883. eCollection 2015.

30.

Deficiency of Factor VII activating protease alters the outcome of ischemic stroke in mice.

Joshi AU, Orset C, Engelhardt B, Baumgart-Vogt E, Gerriets T, Vivien D, Kanse SM.

Eur J Neurosci. 2015 Apr;41(7):965-75. doi: 10.1111/ejn.12830. Epub 2015 Jan 23.

PMID:
25615590
31.

Defective thrombus formation in mice lacking endogenous factor VII activating protease (FSAP).

Subramaniam S, Thielmann I, Morowski M, Pragst I, Sandset PM, Nieswandt B, Etscheid M, Kanse SM.

Thromb Haemost. 2015 Apr;113(4):870-80. doi: 10.1160/TH14-06-0519. Epub 2014 Nov 27.

PMID:
25427855
32.

Factor VII activating protease (FSAP): a novel protective factor in liver fibrosis.

Martinez-Palacian A, Kanse SM, Weiskirchen R.

Proteomics Clin Appl. 2014 Jun;8(5-6):438-46. doi: 10.1002/prca.201300078. Epub 2014 Mar 26. Review.

PMID:
24497464
33.

Regulation of monocyte/macrophage function by factor VII activating protease (FSAP).

Parahuleva MS, Maj R, Hölschermann H, Parviz B, Abdallah Y, Erdogan A, Tillmanns H, Kanse SM.

Atherosclerosis. 2013 Oct;230(2):365-72. doi: 10.1016/j.atherosclerosis.2013.08.007. Epub 2013 Aug 16.

PMID:
24075769
34.

Association of circulating factor seven activating protease (FSAP) and of oral Omega-3 fatty acids supplements with clinical outcome in patients with atrial fibrillation: the OMEGA-AF study.

Parahuleva MS, Kanse S, Hölschermann H, Zheleva K, Zandt D, Worsch M, Parviz B, Güttler N, Tillmanns H, Böning A, Erdogan A.

J Thromb Thrombolysis. 2014 Apr;37(3):317-25. doi: 10.1007/s11239-013-0921-0.

PMID:
23575879
35.

The factor VII-activating protease (FSAP) enhances the activity of bone morphogenetic protein-2 (BMP-2).

Roedel EK, Schwarz E, Kanse SM.

J Biol Chem. 2013 Mar 8;288(10):7193-203. doi: 10.1074/jbc.M112.433029. Epub 2013 Jan 22.

36.

Factor seven activating protease (FSAP) expression in human placenta and its role in trophoblast migration.

Parahuleva MS, Ball N, Parviz B, Zandt D, Abdallah Y, Tillmanns H, Hoelschermann H, Kanse SM.

Eur J Obstet Gynecol Reprod Biol. 2013 Mar;167(1):34-40. doi: 10.1016/j.ejogrb.2012.10.035. Epub 2012 Dec 4.

PMID:
23218959
37.

The vitamin K-dependent anticoagulant factor, protein S, inhibits multiple VEGF-A-induced angiogenesis events in a Mer- and SHP2-dependent manner.

Fraineau S, Monvoisin A, Clarhaut J, Talbot J, Simonneau C, Kanthou C, Kanse SM, Philippe M, Benzakour O.

Blood. 2012 Dec 13;120(25):5073-83. doi: 10.1182/blood-2012-05-429183. Epub 2012 Oct 12.

38.

At the interface of fibrinolysis and inflammation: the role of urokinase-type plasminogen activator in the leukocyte extravasation cascade.

Reichel CA, Kanse SM, Krombach F.

Trends Cardiovasc Med. 2012 Oct;22(7):192-6. doi: 10.1016/j.tcm.2012.07.019. Epub 2012 Oct 10. Review.

PMID:
23062972
39.

Factor VII activating protease (FSAP) exerts anti-inflammatory and anti-fibrotic effects in liver fibrosis in mice and men.

Borkham-Kamphorst E, Zimmermann HW, Gassler N, Bissels U, Bosio A, Tacke F, Weiskirchen R, Kanse SM.

J Hepatol. 2013 Jan;58(1):104-11. doi: 10.1016/j.jhep.2012.09.007. Epub 2012 Sep 16. Erratum in: J Hepatol. 2014 Oct;61(4):967.

PMID:
22989567
40.

The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity.

Etscheid M, Muhl L, Pons D, Jukema JW, König H, Kanse SM.

Thromb Res. 2012 Dec;130(6):935-41. doi: 10.1016/j.thromres.2012.07.023. Epub 2012 Aug 18.

PMID:
22906531
41.

Nicotine modulation of factor VII activating protease (FSAP) expression in human monocytes.

Parahuleva MS, Langanke E, Hölschermann H, Parviz B, Abdallah Y, Stracke S, Tillmanns H, Kanse SM.

J Atheroscler Thromb. 2012;19(11):962-9. Epub 2012 Aug 9.

42.

Circulating factor VII activating protease (FSAP) is associated with clinical outcome in acute coronary syndrome.

Parahuleva MS, Hölschermann H, Zandt D, Pons-Kühnemann J, Parviz B, Weiskirchen R, Staubitz A, Tillmanns H, Erdogan A, Kanse SM.

Circ J. 2012;76(11):2653-61. Epub 2012 Jul 28.

43.

Plasma factor VII-activating protease antigen levels and activity are increased in ischemic stroke.

Hanson E, Kanse SM, Joshi A, Jood K, Nilsson S, Blomstrand C, Jern C.

J Thromb Haemost. 2012 May;10(5):848-56. doi: 10.1111/j.1538-7836.2012.04692.x.

44.

Factor VII-activating protease is activated in multiple trauma patients and generates anaphylatoxin C5a.

Kanse SM, Gallenmueller A, Zeerleder S, Stephan F, Rannou O, Denk S, Etscheid M, Lochnit G, Krueger M, Huber-Lang M.

J Immunol. 2012 Mar 15;188(6):2858-65. doi: 10.4049/jimmunol.1103029. Epub 2012 Feb 3.

45.

Cathepsin D is released after severe tissue trauma in vivo and is capable of generating C5a in vitro.

Huber-Lang M, Denk S, Fulda S, Erler E, Kalbitz M, Weckbach S, Schneider EM, Weiss M, Kanse SM, Perl M.

Mol Immunol. 2012 Feb;50(1-2):60-5. doi: 10.1016/j.molimm.2011.12.005. Epub 2012 Jan 14.

PMID:
22244896
46.

Factor VII-activating protease promotes the proteolysis and inhibition of tissue factor pathway inhibitor.

Kanse SM, Declerck PJ, Ruf W, Broze G, Etscheid M.

Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):427-33. doi: 10.1161/ATVBAHA.111.238394. Epub 2011 Nov 23.

47.

Urokinase-type plasminogen activator promotes paracellular transmigration of neutrophils via Mac-1, but independently of urokinase-type plasminogen activator receptor.

Reichel CA, Uhl B, Lerchenberger M, Puhr-Westerheide D, Rehberg M, Liebl J, Khandoga A, Schmalix W, Zahler S, Deindl E, Lorenzl S, Declerck PJ, Kanse S, Krombach F.

Circulation. 2011 Oct 25;124(17):1848-59. doi: 10.1161/CIRCULATIONAHA.110.017012. Epub 2011 Oct 3.

PMID:
21969013
48.

Factor VII Activating Protease Polymorphism (G534E) Is Associated with Increased Risk for Stroke and Mortality.

Trompet S, Pons D, Kanse SM, de Craen AJ, Ikram MA, Verschuren JJ, Zwinderman AH, Doevendans PA, Tio RA, de Winter RJ, Slagboom PE, Westendorp RG, Jukema JW.

Stroke Res Treat. 2011;2011:424759. doi: 10.4061/2011/424759. Epub 2011 Jun 30.

49.

Factor VII activating protease. Single nucleotide polymorphisms light the way.

Kanse SM, Etscheid M.

Hamostaseologie. 2011 Aug;31(3):174-6, 177-8. doi: 10.5482/ha-1159. Epub 2011 Jun 8. Review.

PMID:
21655671
50.

A model to predict radon exhalation from walls to indoor air based on the exhalation from building material samples.

Sahoo BK, Sapra BK, Gaware JJ, Kanse SD, Mayya YS.

Sci Total Environ. 2011 Jun 1;409(13):2635-41. doi: 10.1016/j.scitotenv.2011.03.031. Epub 2011 Apr 11.

PMID:
21482430

Supplemental Content

Support Center